Medical Pharmaceuticals The most-up-to-date pharmaceutical news stories, including medical, cosmetic, and supplemental treatments. This section contains releases covering all aspects of the pharmaceutical sector, from research, development, and testing, through to product launches and marketing. Topics include clinical trials and studies, as well as updates on the FDA approval process for new treatment options. Learn about upcoming events, conferences, and educational initiatives. Also included is financial and corporate information from the sector, such as board decisions, appointments and changes, industry awards, and quarterly reports.

Latest

Apr 19, 2018, 05:00 ET OBI Pharma Announces FDA Clearance of OBI-3424 IND Application for A Phase I/II Study Targeting AKR1C3 Solid Tumors

OBI Pharma, Inc., a Taiwan biopharma company (TPEx: 4174), today announced that the U.S. Food and Drug Administration (FDA) has cleared an...


Apr 19, 2018, 05:00 ET OBI Pharma erhält FDA-Genehmigung für IND-Antrag auf Phase-I/II-Studie zu OBI-3424 bei AKR1C3-exprimierenden soliden Tumoren

Erste klinische Studie zur Prüfung der Sicherheit und Wirksamkeit eines neuartigen zielgerichteten First-in-Class-Therapeutikums (kleinmolekulares...


Apr 19, 2018, 05:00 ET OBI Pharma annonce l'approbation par la FDA de sa demande de DNR pour une étude de phase I/II de l'OBI-3424 dans le traitement des tumeurs solides exprimant l'enzyme AKR1C3

Première étude clinique testant la sécurité et l'efficacité d'une thérapie ciblée innovante (promédicament à petites molécules) qui libère de...


Apr 19, 2018, 04:30 ET Invitation - Presentation of Sobi's Q1 2018 Results

On 26 April, at 08:00 CET, Swedish Orphan Biovitrum AB (publ) (Sobi™) will publish its report for the first quarter 2018. Financial analysts and...


Apr 19, 2018, 04:00 ET Neuropeptide Y Y1 receptor Structures Offer New Opportunities for Anti-obesity Drug Discovery

- Structures of human neuropeptide Y receptor Y1R reveal drug recognition mechanisms Obesity is a major public health concern. Each year,...


Apr 19, 2018, 03:52 ET Společnost Swift Biosciences představuje rakovinové panely Accel-Amplicon Plus pro iniciativy přesné medicíny

Nový cílový pracovní postup zaměřený na sekvenování kombinuje předem ověřený obsah s jednoduchým přizpůsobením a novými analytickými nástroji pro...


Apr 19, 2018, 03:41 ET Management Change in Moberg Pharma

Moberg Pharma AB (OMX: MOB) announces that Kjell Rensfeldt, VP Research and Development, will retire in the fall but remain with the company...


Apr 19, 2018, 03:00 ET Biohaven Pharmaceuticals Announces Additional Phase 3 Rimegepant Data to be Released at Investor Event Held Concurrently with the 2018 American Academy of Neurology Meeting in Los Angeles

Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN) announced today that it will hold an investor event concurrently with the 2018 American...


Apr 19, 2018, 03:00 ET Philips showcases dedicated radiation oncology workflow solutions spanning image acquisition to treatment planning at ESTRO 2018

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, is showcasing its integrated radiation oncology solutions in the...


Apr 18, 2018, 23:54 ET WuXi AppTec Expands Site in the U.S. for Drug Development Testing Services

WuXi AppTec, a leading global pharmaceutical and medical device open-access capability and technology platform company, today announced the opening...


Apr 18, 2018, 19:25 ET Swift Biosciences führt „Accel-Amplicon Plus Cancer Panels" im Rahmen der Initiativen zur Präzisionsmedizin ein

Neuer Workflow für gezielte Sequenzierung kombiniert vorvalidierte Inhalte mit unkomplizierter individueller Anpassung und neuen Analysetools, um...


Apr 18, 2018, 19:17 ET Roche expands indication for cobas® EGFR Mutation Test v2 as a companion diagnostic with TAGRISSO®

Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced it has received approval from the U.S. Food and Drug Administration (FDA) of its...


Apr 18, 2018, 19:11 ET Preliminary Study Suggests Drug May Help Babies with Spinal Muscular Atrophy

A preliminary study suggests that an investigational drug may help increase protein levels in babies with spinal muscular atrophy. The open-label...


Apr 18, 2018, 19:06 ET US FDA Approves TAGRISSO® (osimertinib) As 1st-Line Treatment For EGFR-Mutated Non-Small Cell Lung Cancer

AstraZeneca today announced that the US Food and Drug Administration (FDA) has approved TAGRISSO® (osimertinib) for the 1st-line treatment of...


Apr 18, 2018, 19:01 ET BenevolentAI Raises $115 Million to Extend Its Leading Global Position in the Field of AI Enabled Drug Development

BenevolentAI today announced that it has raised $115 million from new and existing investors at a pre-money valuation of $2 billion in one of the...


Apr 18, 2018, 18:56 ET Performance and Age Management Medicine Offers GAINSWave® in New York

Performance and Age Management Medicine is pleased to announce they now offer GAINSWave! This breakthrough noninvasive medical therapy uses...


Apr 18, 2018, 18:32 ET Restore For Men Offers GAINSWave® in Texas

Restore For Men is pleased to announce they now offer GAINSWave! This breakthrough noninvasive medical therapy uses low-intensity shockwave therapy...


Apr 18, 2018, 18:19 ET HeartStitch® Inc. Announces CE Mark For CoAp Pro Mitral Valve Repair

HeartStitch® has received its CE Mark in the European Union for its device for treatment of mitral valve repair. This approval will provide...


Apr 18, 2018, 18:00 ET Astellas Announces Sale of Certain Agensys Research Facilities to Kite, a Gilead Company

Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, "Astellas" ) and Kite, a Gilead Company (Nasdaq: GILD, President and CEO: John...


Apr 18, 2018, 18:00 ET PATH and Mologic advance a new diagnostic test to support malaria elimination

PATH and United Kingdom-based test developer Mologic have entered an agreement to advance a new rapid diagnostic test to support treatment and...